Daiichi Sankyo (United States)

Recent papers from Daiichi Sankyo (United States)

1. Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancerNature Medicine · 2026
2. Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of FallingJournal of the American College of Cardiology · 2016
3. TURALIO Risk Evaluation and Mitigation Strategy Program: 6-year retrospective hepatic safety assessmentPatient Related Outcome Measures · 2026
4. Quizartinib in older patients (aged ≥60 years) with newly diagnosed FLT3-ITDpositive acute myeloid leukemia: subgroup analyses from QuANTUM-FirstHaematologica · 2026
5. GENZ-AF-IBD study design: a hybrid phase 4 clinical equivalence trial using AI-based synthetic control arms to compare generic apixaban with the originator in patients with atrial fibrillationEuropean Heart Journal · 2026
6. On-label versus off-label direct oral anticoagulant dosing patterns and associated outcomes in atrial fibrillation: a real-world cohort analysisEuropean Heart Journal · 2026
7. Risk stratification and long-term outcomes in patients with chest pain and cardiac troponin flat curveEuropean Heart Journal · 2026
8. A Transgenic Rat Model of DXd ADC ‐Related Interstitial Pneumonitis for Mechanistic and Translational ResearchCancer Science · 2026
9. Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver DiseaseJournal of the American College of Cardiology · 2019
10. Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac DiseaseJournal of the American College of Cardiology · 2022
11. Olaparib plus tremelimumab in women with recurrent ovarian cancer and a germline BRCA1 or BRCA2 mutation: a phase I/II studyNature Communications · 2026
12. Nonclinical Development of Oligonucleotide-Based Therapeutics: Insights from an IQ DruSafe ONT Working Group SurveyNucleic Acid Therapeutics · 2026
13. Early Direct Oral Anticoagulant Initiation After Intracranial Hemorrhage Among Japanese Patients With Nonvalvular Atrial Fibrillation ― SAFE-ICH Registry 12-Month Outcomes ―Circulation Reports · 2026
14. Transcatheter Valve Size and Clinical Outcomes in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve ImplantationStructural Heart · 2026
15. Development of Potent and Orally Bioavailable MALT1 Inhibitors for Sjogren’s Syndrome: Efficacy and Safety AssessmentACS Medicinal Chemistry Letters · 2026
16. Exposure‐Response Analyses of Datopotamab Deruxtecan (Dato‐ DXd ), a TROP2 ‐Directed Antibody‐Drug Conjugate, in Advanced Non‐small Cell Lung CancerClinical Pharmacology & Therapeutics · 2026
17. Integrating Patient‐Centric Clinical Pharmacology and MID3 to Advance Biologic Development in Immune‐Mediated Inflammatory DiseasesClinical Pharmacology & Therapeutics · 2026
18. Quantitative Systems Pharmacology (QSP): Bridging Biology and Mechanism with Clinical Drug Development DecisionsThe Journal of Clinical Pharmacology · 2026
19. Discovery of Forvisirvat (DS-7830a/SP-624), a Brain-Penetrant Sirtuin 6 Activator Derived from Griseofulvin with Antidepressant-Like EffectsACS Medicinal Chemistry Letters · 2026
20. Implementation of a National Pediatric Cancer Registry in Ethiopia: A systems (“A3”) thinking approachPLoS ONE · 2026